BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 37691866)

  • 1. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.
    Zhou C; Qin Y; Zhao W; Liang Z; Li M; Liu D; Bai L; Chen Y; Chen Y; Cheng Y; Chu T; Chu Q; Deng H; Dong Y; Fang W; Fu X; Gao B; Han Y; He Y; Hong Q; Hu J; Hu Y; Jiang L; Jin Y; Lan F; Li Q; Li S; Li W; Li Y; Liang W; Lin G; Lin X; Liu M; Liu X; Liu X; Liu Z; Lv T; Mu C; Ouyang M; Qin J; Ren S; Shi H; Shi M; Su C; Su J; Sun D; Sun Y; Tang H; Wang H; Wang K; Wang K; Wang M; Wang Q; Wang W; Wang X; Wang Y; Wang Z; Wang Z; Wu L; Wu D; Xie B; Xie M; Xie X; Xie Z; Xu S; Xu X; Yang X; Yin Y; Yu Z; Zhang J; Zhang J; Zhang J; Zhang X; Zhang Y; Zhong D; Zhou Q; Zhou X; Zhou Y; Zhu B; Zhu Z; Zou C; Zhong N; He J; Bai C; Hu C; Li W; Song Y; Zhou J; Han B; Varga J; Barreiro E; Park HY; Petrella F; Saito Y; Goto T; Igai H; Bravaccini S; Zanoni M; Solli P; Watanabe S; Fiorelli A; Nakada T; Ichiki Y; Berardi R; Tsoukalas N; Girard N; Rossi A; Passaro A; Hida T; Li S; Chen L; Chen R
    Transl Lung Cancer Res; 2023 Aug; 12(8):1661-1701. PubMed ID: 37691866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease.
    Mao X; Hu F; Peng J; Zhao Y; Gu A; Fang W; Wang M; Zheng D; Chen G; Dong X; Tan X; Chen Y; Liu X; Cheng X; Zhang X; Hong Q; Hu J; Wang J; Xu Y; Li F; Liang X; Li S; Jiang L; ;
    Ann Palliat Med; 2022 May; 11(5):1605-1623. PubMed ID: 35672889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, diagnosis, and treatment of chronic obstructive pulmonary disease in a hospitalized lung cancer population: a single center study.
    Qu H; Zhu M; Shan C; Ji X; Ji G; Zhang W; Zhang H; Chen B
    J Thorac Dis; 2023 Aug; 15(8):4182-4197. PubMed ID: 37691644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus.
    Al-Moamary MS; Köktūrk N; Idrees MM; Şen E; Juvelekian G; Saleh WA; Zoumot Z; Behbehani N; Hatem A; Masoud HH; Snouber A; van Zyl-Smit RN
    Respir Med; 2021; 189():106641. PubMed ID: 34649155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.
    Recio Iglesias J; Díez-Manglano J; López García F; Díaz Peromingo JA; Almagro P; Varela Aguilar JM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1015-1037. PubMed ID: 32440113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer.
    Gottlieb M; Marsaa K; Godtfredsen NS; Mellemgaard A
    Acta Oncol; 2015 May; 54(5):767-71. PubMed ID: 25907821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
    Mazzone PJ; Gould MK; Arenberg DA; Chen AC; Choi HK; Detterbeck FC; Farjah F; Fong KM; Iaccarino JM; Janes SM; Kanne JP; Kazerooni EA; MacMahon H; Naidich DP; Powell CA; Raoof S; Rivera MP; Tanner NT; Tanoue LK; Tremblay A; Vachani A; White CS; Wiener RS; Silvestri GA
    Radiol Imaging Cancer; 2020 May; 2(3):e204013. PubMed ID: 33778716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating uncertainty: contrasting the communication experiences of patients with advanced COPD and incurable lung cancer.
    Ngwenya N; Crang C; Farquhar M; Rintoul RC; Mahadeva R; Calvert LD; Murray SA; Barclay S
    Fam Pract; 2021 Sep; 38(5):637-643. PubMed ID: 33871548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations.
    Iqbal A; Schloss S; George D; Isonaka S
    Respirology; 2002 Sep; 7(3):233-9. PubMed ID: 12153689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
    ; ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.
    Ardatskaya MD; Ponomareva EV; Shevtsov VV; Evdokimova SA; Odintsov SV
    Eksp Klin Gastroenterol; 2016; (11):17-25. PubMed ID: 29889440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
    Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
    J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
    Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
    S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.
    Koblizek V; Chlumsky J; Zindr V; Neumannova K; Zatloukal J; Zak J; Sedlak V; Kocianova J; Zatloukal J; Hejduk K; Pracharova S;
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):189-201. PubMed ID: 23733084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality Improvement Initiatives to Optimize the Management of Chronic Obstructive Pulmonary Disease in Patients With Lung Cancer.
    Digby GC; Robinson A
    J Oncol Pract; 2017 Nov; 13(11):e957-e965. PubMed ID: 28841364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy.
    Lin M; Huang Z; Chen Y; Xiao H; Wang T
    Front Immunol; 2022; 13():1038715. PubMed ID: 36532019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled treatment of COPD: a Delphi consensus statement.
    Ninane V; Corhay JL; Germonpré P; Janssens W; Joos GF; Liistro G; Vincken W; Gurdain S; Vanvlasselaer E; Lehouck A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():793-801. PubMed ID: 28293106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.